You said it ... Trolls at your level do misinformation ...
Fortunately there is the admirable work of Adrien, Remundo, VetusLignum and a few others ...
izentrop wrote:As for HCQ, let's not repeat the same scenario
The problem with ivermectin is determining at what minimum dose it 'would' have an effect. While for hydroxychloroquine, the dose is known.
As much as there is no hindsight on the new molecules, it would be necessary to stop this sterile discrimination of hydroxychloroquine. And the reason is easy to understand, the score to beat is 0,5% lethality ... Since those are the numbers ...
And this molecule (HCQ) is the most studied and the one of which a significant percentage of studies - and especially observational studies - give more than encouraging signs on its use, the only current one, it is this molecule, and question of the best probabilities of cure VS risk close to “zero”, would have to quote me any alternative: I see no other .... And the fact that instead there is nothing else, you shouldn't quibble guys ... oh yes, we just improved patient care and comfort (“fair” but essential ...) given the effects of anticoagulants, etc ...
Hydroxychloroquine can do no harm, on the contrary, since it will basify the cellular environment, which will improve the assimilation of other molecules at the same level (and it is played out at tenth of pH ...):
even if it only had a placebo effect, it would be good to take, but it will necessarily be much more (because there is an effect at the level of the expectation of the molecule, I know, it is “bad” )
Azithromycin is known to have an effect on infections, and you can help prepare to multiply the effects of such treatment
post412060.html # p412060